Strategic partnerships Mindset Health has established traction with healthcare providers and insurers, evidenced by partnerships with Health Insurance Fund of WA and broad clinician adoption of Nerva. This presents a sales opportunity to scale collaborations with payer networks and health plans seeking evidence-based digital therapeutics for GI conditions.

Clinical validation Nerva’s randomized controlled trial showing meaningful improvements and usage by over 300,000 people demonstrates strong outcomes data. This provides a compelling value proposition for clinics and health systems aiming to improve IBS care pathways with AI-driven brain-gut therapy.

Data advantage Mindset Health operates on the world’s largest proprietary gut-brain therapy dataset, including millions of hypnotherapy sessions and real transcripts. A sales angle is the capability to offer personalized AI therapeutics and scalable digital interventions backed by rich clinical data.

Expansion potential With plans to develop additional digital therapeutics for anxiety, sleep, and chronic pain and a growth trajectory supported by Series A funding, there are cross-sell opportunities to healthcare providers serving multiple chronic conditions and population health programs.

Industry credibility Recognition as a top workplace and active involvement in CALD dementia training initiatives signal credibility and thought leadership. This can be leveraged to engage hospital networks, philanthropy-aligned health initiatives, and government or research partnerships seeking vetted digital health vendors.